A new publication referencing bradykinin was released on October 20, 2026. The paper, titled "Sleep, inflammation, and pain in musculoskeletal rehabilitation: a structured integrative review of neurobiological mechanisms and non-pharmacological pain management strategies," appeared in the journal Pain Management.
This is a structured integrative review, according to the publication title. The review covers neurobiological mechanisms and non-pharmacological pain management strategies in the context of musculoskeletal rehabilitation. Bradykinin is noted in connection with this review's subject matter.
No specific findings, results, or conclusions from the review have been detailed here. Bradykinin remains classified as an unapproved compound used in research settings. This brief reports only the existence and bibliographic details of the publication as listed.
Readers interested in the broader context of bradykinin, including its research background and regulatory status, can consult the compound overview for additional information.